Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT05687578

PUER ("Previously Unrecognized Emerging Risks") Life Clinical Study

A Prospective, Non-Randomized, Multi-Center Observational Study to Establish a Physical Baseline Profile for Individual Study Subjects Using Various Modalities and Identify Deviations Via Longitudinal Monitoring That May Develop Over Time

Status
Enrolling By Invitation
Phase
Study type
Observational
Enrollment
10,000 (estimated)
Sponsor
Puer Research, LLC · Network
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Accepted

Summary

This is a minimal risk, prospective, non-randomized, multi-center population based observational study to establish a physical baseline profile for individual study subjects using various modalities (blood draws, non-invasive imaging, stool samples, saliva samples) and identify deviations through longitudinal monitoring that may develop over time and may be relevant to human health and healthy longevity.

Detailed description

The two key elements of the PUER Research protocol include (1) molecular and laboratory profiling and (2) non-invasive imaging and wearables/ "quantified self" measurements. All elements are optional. Molecular assessments will be conducted using peripheral blood samples, and potentially urine, stool or saliva samples. Non-invasive imaging assessment will consist of magnetic resonance imaging (MRI) and computerized tomography (CT) scans, ultrasound, and x-ray. All imaging modalities are optional. Other functional assessments, including respiratory, cardiac and other functions, as well as self-quantifiable assessments via wearables, may also be conducted and are optional. The study will result in longitudinal data collection to inform if any modalities employed here can inform of baseline deviations for individuals. Researchers at study sites will not be blinded to the data being collected during this study.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTMeasurements OnlyThis is an observational study only using biospecimen and imaging-based measurements only

Timeline

Start date
2023-03-27
Primary completion
2029-01-01
Completion
2030-01-01
First posted
2023-01-18
Last updated
2024-10-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05687578. Inclusion in this directory is not an endorsement.